Riskpilot← Back to searchSign inGet full accessBylock Labs AB
ABActiveOrg 5590436886Strandvägen 7 AMedia representation · NACE 7312Est. 20150 employees
Revenue 2024
SEK 470K
+2270% vs 2023
EBITDA margin
21.7%
+1438% vs 2023
Equity ratio
70.3%
Financial strength
Net profit 2024
SEK 82K
+1012% vs 2023
| Revenue | SEK 470K | +2270% |
| EBITDA | SEK 102K | +1438% |
| Net profit | SEK 82K | +1012% |
| Total assets | SEK 189K | +269% |
| Equity | SEK 133K | +161% |
| Employees | 0 | — |
Legal name
Bylock Labs AB
Org number
5590436886
Legal form
Aktiebolag
NACE code
7312 · Media representation
Founded
21 december 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utveckling av biotekniska innovationer inom medicin och teknik. Utveckling av mobilapplikationer, datorspel och filmproduktion.
Address
Strandvägen 7 A
Email
labs@bylock.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 | 0 | 0 | 20 | 470 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 | −2 | — | 7 | 102 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 3 | −2 | 0 | 7 | 102 |
| Net financials | — | — | 0 | 1 | 1 |
| Profit before tax | 3 | −2 | 0 | 8 | 103 |
| Tax | −0 | −0 | — | −0 | −21 |
| Net profit | 3 | −2 | 0 | 7 | 82 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 46 | 43 | 44 | 51 | 189 |
| Equity | 46 | 43 | 44 | 51 | 133 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | — | 0 | 56 |
| Total debt | — | — | — | 0 | 56 |
EBITDA margin
21.7%
This company
15.8%
Market median
+37% vs market
20202024
Equity ratio
70.3%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
61.6%
This company
18.4%
Market median
+235% vs market
20202024
Net profit margin
17.4%
This company
8.1%
Market median
+115% vs market
20202024
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
20202024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bylock Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Christoffer Bylock | Chief Executive Officer | 0 companies |
| Maria Andreevna Koval | Deputy Board Member | 0 companies |
| Neo Bylock Hulterstedt | Deputy Board Member | 0 companies |